The Ebola outbreak in West Africa has inspired widespread fear throughout the U.S. and in many other countries. In reality, the threat of Ebola is actually quite small with only 1,700 deaths since 1976. The rarity of the Ebola virus has given major pharmaceutical companies very little incentive to develop a treatment for the virus given that the market for such a drug would be almost nonexistent. However, BioCryst Pharmaceuticals, a small pharmaceutical company based in Frederick, MD, has been given government help to develop a cure for the virus. Listen to learn more about the complexity of the Ebola virus and what is being done to develop a cure.
Story Length: 4:11
© 2014 National Public Radio, Inc. Used with the permission of NPR. All rights reserved.
AIR DATE: 04/11/2014